Pharma & Healthcare
Global Pimozide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 12, 25
- ID: 307199
- Pages: 124
- Figures: 127
- Views: 1
In 2024, the global market size of Pimozide was estimated to be worth US$ 10.8 million and is forecast to reach approximately US$ 10.1 million by 2031 with a CAGR of -0.9% during the forecast period 2025-2031.
Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
Global Pimozide key players include Teva, Par Pharmaceutical, Johnson & Johnson, etc. Global top three manufacturers hold a share about 80%.
North America is the largest market, with a share about 40%, followed by Europe and South America, both have a share about 45 percent.
In terms of product, 2Mg is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospitals, followed by Drugstores, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pimozide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pimozide.
The Pimozide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pimozide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pimozide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma
Segment by Type
1Mg
2Mg
4Mg
Segment by Application
Hospitals
Drugstores
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pimozide in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Pimozide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pimozide sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
Global Pimozide key players include Teva, Par Pharmaceutical, Johnson & Johnson, etc. Global top three manufacturers hold a share about 80%.
North America is the largest market, with a share about 40%, followed by Europe and South America, both have a share about 45 percent.
In terms of product, 2Mg is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospitals, followed by Drugstores, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pimozide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pimozide.
The Pimozide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pimozide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pimozide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma
Segment by Type
1Mg
2Mg
4Mg
Segment by Application
Hospitals
Drugstores
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pimozide in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Pimozide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pimozide sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Pimozide Product Introduction
1.2 Market by Type
1.2.1 Global Pimozide Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 1Mg
1.2.3 2Mg
1.2.4 4Mg
1.3 Market by Application
1.3.1 Global Pimozide Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pimozide Market Size Estimates and Forecasts
2.1.1 Global Pimozide Revenue 2020-2031
2.1.2 Global Pimozide Sales 2020-2031
2.2 Pimozide Market Size by Region: 2024 Versus 2031
2.3 Pimozide Sales by Region (2020-2031)
2.3.1 Global Pimozide Sales by Region: 2020-2025
2.3.2 Global Pimozide Sales Forecast by Region (2026-2031)
2.3.3 Global Pimozide Sales Market Share by Region (2020-2031)
2.4 Pimozide Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Pimozide Revenue by Region: 2020-2025
2.4.2 Global Pimozide Revenue Forecast by Region (2026-2031)
2.4.3 Global Pimozide Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Pimozide Sales by Type (2020-2031)
3.1.1.1 Global Pimozide Sales Volume by Type (2020-2031)
3.1.1.2 Global Pimozide Sales Market Share by Type (2020-2031)
3.1.2 Global Pimozide Revenue by Type (2020-2031)
3.1.2.1 Global Pimozide Revenue by Type (2020-2031)
3.1.2.2 Global Pimozide Revenue Market Share by Type (2020-2031)
3.1.3 Pimozide Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Pimozide Sales by Application (2020-2031)
3.2.1.1 Global Pimozide Sales Volume by Application (2020-2031)
3.2.1.2 Global Pimozide Sales Market Share by Application (2020-2031)
3.2.2 Global Pimozide Revenue by Application (2020-2031)
3.2.2.1 Global Pimozide Revenue by Application (2020-2031)
3.2.2.2 Global Pimozide Revenue Market Share by Application (2020-2031)
3.2.3 Pimozide Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 1Mg of Pimozide Revenue Market Share by Application
3.3.2 2Mg of Pimozide Revenue Market Share by Application
3.3.3 4Mg of Pimozide Revenue Market Share by Application
4 Global Pimozide by Manufacturers
4.1 Global Top Pimozide Manufacturers by Sales (2020-2025)
4.1.1 Global Pimozide Sales by Manufacturer (2020-2025)
4.1.2 Global Pimozide Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Pimozide Manufacturers by Revenue (2020-2025)
4.2.1 Global Pimozide Revenue by Manufacturer (2020-2025)
4.2.2 Global Pimozide Revenue Share by Manufacturer (2020-2025)
4.3 Global Pimozide Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Pimozide Manufacturers Covered: Ranking by Revenue
4.4.2 Global Pimozide Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Pimozide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Pimozide Manufacturing Base Distribution, Product Type
4.5.1 Pimozide Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Pimozide Market
4.5.3 Manufacturers Pimozide Product Type and Application
4.5.4 1Mg Market Sales of Pimozide by Manufacturer
4.5.5 2Mg Market Sales of Pimozide by Manufacturer
4.5.6 4Mg Market Sales of Pimozide by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Teva
5.1.1 Teva Company Information
5.1.2 Teva Description, Business Overview
5.1.3 Teva Pimozide Products Offered
5.1.4 Teva Pimozide Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Teva Pimozide Sales by Product in 2024
5.1.6 Teva Pimozide Sales by Application in 2024
5.1.7 Teva Pimozide Sales by Geographic Area in 2024
5.1.8 Teva Recent Developments
5.2 Par Pharmaceutical
5.2.1 Par Pharmaceutical Company Information
5.2.2 Par Pharmaceutical Description, Business Overview
5.2.3 Par Pharmaceutical Pimozide Products Offered
5.2.4 Par Pharmaceutical Pimozide Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Par Pharmaceutical Pimozide Sales by Product in 2024
5.2.6 Par Pharmaceutical Pimozide Sales by Application in 2024
5.2.7 Par Pharmaceutical Pimozide Sales by Geographic Area in 2024
5.2.8 Par Pharmaceutical Recent Developments
5.3 Johnson & Johnson
5.3.1 Johnson & Johnson Company Information
5.3.2 Johnson & Johnson Description, Business Overview
5.3.3 Johnson & Johnson Pimozide Products Offered
5.3.4 Johnson & Johnson Pimozide Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Johnson & Johnson Pimozide Sales by Product in 2024
5.3.6 Johnson & Johnson Pimozide Sales by Application in 2024
5.3.7 Johnson & Johnson Pimozide Sales by Geographic Area in 2024
5.3.8 Johnson & Johnson Recent Developments
5.4 Eumedica
5.4.1 Eumedica Company Information
5.4.2 Eumedica Description, Business Overview
5.4.3 Eumedica Pimozide Products Offered
5.4.4 Eumedica Pimozide Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Eumedica Pimozide Sales by Product in 2024
5.4.6 Eumedica Pimozide Sales by Application in 2024
5.4.7 Eumedica Pimozide Sales by Geographic Area in 2024
5.4.8 Eumedica Recent Developments
5.5 Pharmascience
5.5.1 Pharmascience Company Information
5.5.2 Pharmascience Description, Business Overview
5.5.3 Pharmascience Pimozide Products Offered
5.5.4 Pharmascience Pimozide Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Pharmascience Pimozide Sales by Product in 2024
5.5.6 Pharmascience Pimozide Sales by Application in 2024
5.5.7 Pharmascience Pimozide Sales by Geographic Area in 2024
5.5.8 Pharmascience Recent Developments
5.6 Domina Pharmaceuticals
5.6.1 Domina Pharmaceuticals Company Information
5.6.2 Domina Pharmaceuticals Description, Business Overview
5.6.3 Domina Pharmaceuticals Pimozide Products Offered
5.6.4 Domina Pharmaceuticals Pimozide Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Domina Pharmaceuticals Pimozide Sales by Product in 2024
5.6.6 Domina Pharmaceuticals Pimozide Sales by Application in 2024
5.6.7 Domina Pharmaceuticals Pimozide Sales by Geographic Area in 2024
5.6.8 Domina Pharmaceuticals Recent Developments
5.7 Aa Pharma
5.7.1 Aa Pharma Company Information
5.7.2 Aa Pharma Description, Business Overview
5.7.3 Aa Pharma Pimozide Products Offered
5.7.4 Aa Pharma Pimozide Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Aa Pharma Pimozide Sales by Product in 2024
5.7.6 Aa Pharma Pimozide Sales by Application in 2024
5.7.7 Aa Pharma Pimozide Sales by Geographic Area in 2024
5.7.8 Aa Pharma Recent Developments
6 North America
6.1 North America Pimozide Market Size YoY Growth 2020-2031
6.2 North America Pimozide Market Facts & Figures by Country
6.2.1 North America Pimozide Sales by Country (2020-2031)
6.2.2 North America Pimozide Revenue by Country (2020-2031)
6.3 North America Pimozide Sales by Type (2020-2025)
6.4 North America Pimozide Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Pimozide Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Pimozide Market Facts & Figures by Region
7.2.1 Asia-Pacific Pimozide Sales by Region (2020-2031)
7.2.2 Asia-Pacific Pimozide Revenue by Region (2020-2031)
7.3 Asia-Pacific Pimozide Sales by Type (2020-2025)
7.4 Asia-Pacific Pimozide Sales by Application (2020-2025)
8 Europe
8.1 Europe Pimozide Market Size YoY Growth 2020-2031
8.2 Europe Pimozide Market Facts & Figures by Country
8.2.1 Europe Pimozide Sales by Country (2020-2031)
8.2.2 Europe Pimozide Revenue by Country (2020-2031)
8.3 Europe Pimozide Sales by Type (2020-2025)
8.4 Europe Pimozide Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Pimozide Market Size YoY Growth 2020-2031
9.2 Latin America Pimozide Market Facts & Figures by Country
9.2.1 Latin America Pimozide Sales by Country (2020-2031)
9.2.2 Latin America Pimozide Revenue by Country (2020-2031)
9.3 Latin America Pimozide Sales by Type (2020-2025)
9.4 Latin America Pimozide Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Pimozide Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Pimozide Market Facts & Figures by Country
10.2.1 Middle East and Africa Pimozide Sales by Country (2020-2031)
10.2.2 Middle East and Africa Pimozide Revenue by Country (2020-2031)
10.3 Middle East and Africa Pimozide Sales by Type (2020-2025)
10.4 Middle East and Africa Pimozide Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Pimozide Supply Chain Analysis
11.2 Pimozide Key Raw Materials and Upstream Suppliers
11.3 Pimozide Clients Analysis
11.4 Pimozide Sales Channel and Sales Model Analysis
11.4.1 Pimozide Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Pimozide Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Pimozide Distributors
12 Pimozide Market Dynamics
12.1 Pimozide Industry Trends
12.2 Pimozide Market Drivers
12.3 Pimozide Market Challenges
12.4 Pimozide Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Pimozide Product Introduction
1.2 Market by Type
1.2.1 Global Pimozide Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 1Mg
1.2.3 2Mg
1.2.4 4Mg
1.3 Market by Application
1.3.1 Global Pimozide Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pimozide Market Size Estimates and Forecasts
2.1.1 Global Pimozide Revenue 2020-2031
2.1.2 Global Pimozide Sales 2020-2031
2.2 Pimozide Market Size by Region: 2024 Versus 2031
2.3 Pimozide Sales by Region (2020-2031)
2.3.1 Global Pimozide Sales by Region: 2020-2025
2.3.2 Global Pimozide Sales Forecast by Region (2026-2031)
2.3.3 Global Pimozide Sales Market Share by Region (2020-2031)
2.4 Pimozide Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Pimozide Revenue by Region: 2020-2025
2.4.2 Global Pimozide Revenue Forecast by Region (2026-2031)
2.4.3 Global Pimozide Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Pimozide Sales by Type (2020-2031)
3.1.1.1 Global Pimozide Sales Volume by Type (2020-2031)
3.1.1.2 Global Pimozide Sales Market Share by Type (2020-2031)
3.1.2 Global Pimozide Revenue by Type (2020-2031)
3.1.2.1 Global Pimozide Revenue by Type (2020-2031)
3.1.2.2 Global Pimozide Revenue Market Share by Type (2020-2031)
3.1.3 Pimozide Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Pimozide Sales by Application (2020-2031)
3.2.1.1 Global Pimozide Sales Volume by Application (2020-2031)
3.2.1.2 Global Pimozide Sales Market Share by Application (2020-2031)
3.2.2 Global Pimozide Revenue by Application (2020-2031)
3.2.2.1 Global Pimozide Revenue by Application (2020-2031)
3.2.2.2 Global Pimozide Revenue Market Share by Application (2020-2031)
3.2.3 Pimozide Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 1Mg of Pimozide Revenue Market Share by Application
3.3.2 2Mg of Pimozide Revenue Market Share by Application
3.3.3 4Mg of Pimozide Revenue Market Share by Application
4 Global Pimozide by Manufacturers
4.1 Global Top Pimozide Manufacturers by Sales (2020-2025)
4.1.1 Global Pimozide Sales by Manufacturer (2020-2025)
4.1.2 Global Pimozide Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Pimozide Manufacturers by Revenue (2020-2025)
4.2.1 Global Pimozide Revenue by Manufacturer (2020-2025)
4.2.2 Global Pimozide Revenue Share by Manufacturer (2020-2025)
4.3 Global Pimozide Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Pimozide Manufacturers Covered: Ranking by Revenue
4.4.2 Global Pimozide Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Pimozide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Pimozide Manufacturing Base Distribution, Product Type
4.5.1 Pimozide Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Pimozide Market
4.5.3 Manufacturers Pimozide Product Type and Application
4.5.4 1Mg Market Sales of Pimozide by Manufacturer
4.5.5 2Mg Market Sales of Pimozide by Manufacturer
4.5.6 4Mg Market Sales of Pimozide by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Teva
5.1.1 Teva Company Information
5.1.2 Teva Description, Business Overview
5.1.3 Teva Pimozide Products Offered
5.1.4 Teva Pimozide Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Teva Pimozide Sales by Product in 2024
5.1.6 Teva Pimozide Sales by Application in 2024
5.1.7 Teva Pimozide Sales by Geographic Area in 2024
5.1.8 Teva Recent Developments
5.2 Par Pharmaceutical
5.2.1 Par Pharmaceutical Company Information
5.2.2 Par Pharmaceutical Description, Business Overview
5.2.3 Par Pharmaceutical Pimozide Products Offered
5.2.4 Par Pharmaceutical Pimozide Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Par Pharmaceutical Pimozide Sales by Product in 2024
5.2.6 Par Pharmaceutical Pimozide Sales by Application in 2024
5.2.7 Par Pharmaceutical Pimozide Sales by Geographic Area in 2024
5.2.8 Par Pharmaceutical Recent Developments
5.3 Johnson & Johnson
5.3.1 Johnson & Johnson Company Information
5.3.2 Johnson & Johnson Description, Business Overview
5.3.3 Johnson & Johnson Pimozide Products Offered
5.3.4 Johnson & Johnson Pimozide Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Johnson & Johnson Pimozide Sales by Product in 2024
5.3.6 Johnson & Johnson Pimozide Sales by Application in 2024
5.3.7 Johnson & Johnson Pimozide Sales by Geographic Area in 2024
5.3.8 Johnson & Johnson Recent Developments
5.4 Eumedica
5.4.1 Eumedica Company Information
5.4.2 Eumedica Description, Business Overview
5.4.3 Eumedica Pimozide Products Offered
5.4.4 Eumedica Pimozide Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Eumedica Pimozide Sales by Product in 2024
5.4.6 Eumedica Pimozide Sales by Application in 2024
5.4.7 Eumedica Pimozide Sales by Geographic Area in 2024
5.4.8 Eumedica Recent Developments
5.5 Pharmascience
5.5.1 Pharmascience Company Information
5.5.2 Pharmascience Description, Business Overview
5.5.3 Pharmascience Pimozide Products Offered
5.5.4 Pharmascience Pimozide Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Pharmascience Pimozide Sales by Product in 2024
5.5.6 Pharmascience Pimozide Sales by Application in 2024
5.5.7 Pharmascience Pimozide Sales by Geographic Area in 2024
5.5.8 Pharmascience Recent Developments
5.6 Domina Pharmaceuticals
5.6.1 Domina Pharmaceuticals Company Information
5.6.2 Domina Pharmaceuticals Description, Business Overview
5.6.3 Domina Pharmaceuticals Pimozide Products Offered
5.6.4 Domina Pharmaceuticals Pimozide Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Domina Pharmaceuticals Pimozide Sales by Product in 2024
5.6.6 Domina Pharmaceuticals Pimozide Sales by Application in 2024
5.6.7 Domina Pharmaceuticals Pimozide Sales by Geographic Area in 2024
5.6.8 Domina Pharmaceuticals Recent Developments
5.7 Aa Pharma
5.7.1 Aa Pharma Company Information
5.7.2 Aa Pharma Description, Business Overview
5.7.3 Aa Pharma Pimozide Products Offered
5.7.4 Aa Pharma Pimozide Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Aa Pharma Pimozide Sales by Product in 2024
5.7.6 Aa Pharma Pimozide Sales by Application in 2024
5.7.7 Aa Pharma Pimozide Sales by Geographic Area in 2024
5.7.8 Aa Pharma Recent Developments
6 North America
6.1 North America Pimozide Market Size YoY Growth 2020-2031
6.2 North America Pimozide Market Facts & Figures by Country
6.2.1 North America Pimozide Sales by Country (2020-2031)
6.2.2 North America Pimozide Revenue by Country (2020-2031)
6.3 North America Pimozide Sales by Type (2020-2025)
6.4 North America Pimozide Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Pimozide Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Pimozide Market Facts & Figures by Region
7.2.1 Asia-Pacific Pimozide Sales by Region (2020-2031)
7.2.2 Asia-Pacific Pimozide Revenue by Region (2020-2031)
7.3 Asia-Pacific Pimozide Sales by Type (2020-2025)
7.4 Asia-Pacific Pimozide Sales by Application (2020-2025)
8 Europe
8.1 Europe Pimozide Market Size YoY Growth 2020-2031
8.2 Europe Pimozide Market Facts & Figures by Country
8.2.1 Europe Pimozide Sales by Country (2020-2031)
8.2.2 Europe Pimozide Revenue by Country (2020-2031)
8.3 Europe Pimozide Sales by Type (2020-2025)
8.4 Europe Pimozide Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Pimozide Market Size YoY Growth 2020-2031
9.2 Latin America Pimozide Market Facts & Figures by Country
9.2.1 Latin America Pimozide Sales by Country (2020-2031)
9.2.2 Latin America Pimozide Revenue by Country (2020-2031)
9.3 Latin America Pimozide Sales by Type (2020-2025)
9.4 Latin America Pimozide Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Pimozide Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Pimozide Market Facts & Figures by Country
10.2.1 Middle East and Africa Pimozide Sales by Country (2020-2031)
10.2.2 Middle East and Africa Pimozide Revenue by Country (2020-2031)
10.3 Middle East and Africa Pimozide Sales by Type (2020-2025)
10.4 Middle East and Africa Pimozide Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Pimozide Supply Chain Analysis
11.2 Pimozide Key Raw Materials and Upstream Suppliers
11.3 Pimozide Clients Analysis
11.4 Pimozide Sales Channel and Sales Model Analysis
11.4.1 Pimozide Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Pimozide Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Pimozide Distributors
12 Pimozide Market Dynamics
12.1 Pimozide Industry Trends
12.2 Pimozide Market Drivers
12.3 Pimozide Market Challenges
12.4 Pimozide Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Pimozide Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Pimozide Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Pimozide Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Pimozide Sales by Region (2020-2025) & (K Units)
Table 5. Global Pimozide Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Pimozide Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Pimozide Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Pimozide Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Pimozide Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Pimozide Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Pimozide Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Pimozide Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Pimozide Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Pimozide Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Pimozide Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Pimozide Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Pimozide Sales Share by Manufacturer (2020-2025)
Table 18. Pimozide Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Pimozide Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Pimozide Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Pimozide Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Pimozide Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Pimozide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pimozide as of 2024)
Table 24. Pimozide Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Pimozide Market
Table 26. Manufacturers Pimozide Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Teva Company Information
Table 29. Teva Description and Business Overview
Table 30. Teva Pimozide Product
Table 31. Teva Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. Teva Sales Proportion of Pimozide by Product in 2024
Table 33. Teva Sales Proportion of Pimozide by Application in 2024
Table 34. Teva Sales Proportion of Pimozide by Geographic Area in 2024
Table 35. Teva Recent Developments
Table 36. Par Pharmaceutical Company Information
Table 37. Par Pharmaceutical Description and Business Overview
Table 38. Par Pharmaceutical Pimozide Product
Table 39. Par Pharmaceutical Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. Par Pharmaceutical Sales Proportion of Pimozide by Product in 2024
Table 41. Par Pharmaceutical Sales Proportion of Pimozide by Application in 2024
Table 42. Par Pharmaceutical Sales Proportion of Pimozide by Geographic Area in 2024
Table 43. Par Pharmaceutical Recent Developments
Table 44. Johnson & Johnson Company Information
Table 45. Johnson & Johnson Description and Business Overview
Table 46. Johnson & Johnson Pimozide Product
Table 47. Johnson & Johnson Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. Johnson & Johnson Sales Proportion of Pimozide by Product in 2024
Table 49. Johnson & Johnson Sales Proportion of Pimozide by Application in 2024
Table 50. Johnson & Johnson Sales Proportion of Pimozide by Geographic Area in 2024
Table 51. Johnson & Johnson Recent Developments
Table 52. Eumedica Company Information
Table 53. Eumedica Description and Business Overview
Table 54. Eumedica Pimozide Product
Table 55. Eumedica Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. Eumedica Sales Proportion of Pimozide by Product in 2024
Table 57. Eumedica Sales Proportion of Pimozide by Application in 2024
Table 58. Eumedica Sales Proportion of Pimozide by Geographic Area in 2024
Table 59. Eumedica Recent Developments
Table 60. Pharmascience Company Information
Table 61. Pharmascience Description and Business Overview
Table 62. Pharmascience Pimozide Product
Table 63. Pharmascience Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Pharmascience Sales Proportion of Pimozide by Product in 2024
Table 65. Pharmascience Sales Proportion of Pimozide by Application in 2024
Table 66. Pharmascience Sales Proportion of Pimozide by Geographic Area in 2024
Table 67. Pharmascience Recent Developments
Table 68. Domina Pharmaceuticals Company Information
Table 69. Domina Pharmaceuticals Description and Business Overview
Table 70. Domina Pharmaceuticals Pimozide Product
Table 71. Domina Pharmaceuticals Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Domina Pharmaceuticals Sales Proportion of Pimozide by Product in 2024
Table 73. Domina Pharmaceuticals Sales Proportion of Pimozide by Application in 2024
Table 74. Domina Pharmaceuticals Sales Proportion of Pimozide by Geographic Area in 2024
Table 75. Domina Pharmaceuticals Recent Developments
Table 76. Aa Pharma Company Information
Table 77. Aa Pharma Description and Business Overview
Table 78. Aa Pharma Pimozide Product
Table 79. Aa Pharma Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Aa Pharma Sales Proportion of Pimozide by Product in 2024
Table 81. Aa Pharma Sales Proportion of Pimozide by Application in 2024
Table 82. Aa Pharma Sales Proportion of Pimozide by Geographic Area in 2024
Table 83. Aa Pharma Recent Developments
Table 84. North America Pimozide Sales by Country (2020-2025) & (K Units)
Table 85. North America Pimozide Sales by Country (2026-2031) & (K Units)
Table 86. North America Pimozide Revenue by Country (2020-2025) & (US$ Million)
Table 87. North America Pimozide Revenue by Country (2026-2031) & (US$ Million)
Table 88. North America Pimozide Sales by Type (2020-2025) & (K Units)
Table 89. North America Pimozide Sales by Application (2020-2025) & (K Units)
Table 90. Asia-Pacific Pimozide Sales by Region (2020-2025) & (K Units)
Table 91. Asia-Pacific Pimozide Sales by Region (2026-2031) & (K Units)
Table 92. Asia-Pacific Pimozide Revenue by Region (2020-2025) & (US$ Million)
Table 93. Asia-Pacific Pimozide Revenue by Region (2026-2031) & (US$ Million)
Table 94. Asia-Pacific Pimozide Sales by Type (2020-2025) & (K Units)
Table 95. Asia-Pacific Pimozide Sales by Application (2020-2025) & (K Units)
Table 96. Europe Pimozide Sales by Country (2020-2025) & (K Units)
Table 97. Europe Pimozide Sales by Country (2026-2031) & (K Units)
Table 98. Europe Pimozide Revenue by Country (2020-2025) & (US$ Million)
Table 99. Europe Pimozide Revenue by Country (2026-2031) & (US$ Million)
Table 100. Europe Pimozide Sales by Type (2020-2025) & (K Units)
Table 101. Europe Pimozide Sales by Application (2020-2025) & (K Units)
Table 102. Latin America Pimozide Sales by Country (2020-2025) & (K Units)
Table 103. Latin America Pimozide Sales by Country (2026-2031) & (K Units)
Table 104. Latin America Pimozide Revenue by Country (2020-2025) & (US$ Million)
Table 105. Latin America Pimozide Revenue by Country (2026-2031) & (US$ Million)
Table 106. Latin America Pimozide Sales by Type (2020-2025) & (K Units)
Table 107. Latin America Pimozide Sales by Application (2020-2025) & (K Units)
Table 108. Middle East and Africa Pimozide Sales by Country (2020-2025) & (K Units)
Table 109. Middle East and Africa Pimozide Sales by Country (2026-2031) & (K Units)
Table 110. Middle East and Africa Pimozide Revenue by Country (2020-2025) & (US$ Million)
Table 111. Middle East and Africa Pimozide Revenue by Country (2026-2031) & (US$ Million)
Table 112. Middle East and Africa Pimozide Sales by Type (2020-2025) & (K Units)
Table 113. Middle East and Africa Pimozide Sales by Application (2020-2025) & (K Units)
Table 114. Pimozide Key Raw Materials, Industry Status and Trend
Table 115. Pimozide Key Raw Materials and Upstream Suppliers
Table 116. Pimozide Clients Status and Trend
Table 117. Pimozide Typical Clients
Table 118. Pimozide Distributors
Table 119. Pimozide Market Trends
Table 120. Pimozide Market Drivers
Table 121. Pimozide Market Challenges
Table 122. Pimozide Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Pimozide Product Picture
Figure 2. Global Pimozide Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Pimozide Sales Market Share by Type in 2024 & 2031
Figure 4. 1Mg Product Picture
Figure 5. 2Mg Product Picture
Figure 6. 4Mg Product Picture
Figure 7. Global Pimozide Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Pimozide Sales Market Share by Application in 2024 & 2031
Figure 9. Hospitals
Figure 10. Drugstores
Figure 11. Others
Figure 12. Pimozide Report Years Considered
Figure 13. Global Pimozide Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Pimozide Market Size 2020-2031 (US$ Million)
Figure 15. Global Pimozide Sales 2020-2031 (K Units)
Figure 16. Global Pimozide Sales Market Share Forecast by Region (2020-2031)
Figure 17. Global Pimozide Revenue Market Share by Region (2020-2031)
Figure 18. Global Pimozide Sales Market Share Forecast by Type (2020-2031)
Figure 19. Global Pimozide Revenue Market Share Forecast by Type (2020-2031)
Figure 20. Pimozide Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 21. Global Pimozide Sales Market Share Forecast by Application (2020-2031)
Figure 22. Global Pimozide Revenue Market Share Forecast by Application (2020-2031)
Figure 23. Pimozide Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 24. 1Mg of Pimozide Revenue Market Share by Application, 2024 VS 2031
Figure 25. 2Mg of Pimozide Revenue Market Share by Application, 2024 VS 2031
Figure 26. 4Mg of Pimozide Revenue Market Share by Application, 2024 VS 2031
Figure 27. Global Pimozide Sales Share by Manufacturer in 2024
Figure 28. Pimozide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 29. 1Mg Market Sales Proportion by Manufacturer in 2024
Figure 30. 2Mg Market Sales Proportion by Manufacturer in 2024
Figure 31. 4Mg Market Sales Proportion by Manufacturer in 2024
Figure 32. North America Pimozide Revenue 2020-2031 (US$ Million)
Figure 33. North America Pimozide Sales Market Share by Type (2020-2025)
Figure 34. North America Pimozide Sales Market Share by Application (2020-2025)
Figure 35. Asia-Pacific Pimozide Revenue 2020-2031 (US$ Million)
Figure 36. Asia-Pacific Pimozide Sales Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Pimozide Revenue Market Share by Region (2020-2031)
Figure 38. Asia-Pacific Pimozide Sales Market Share by Type (2020-2025)
Figure 39. Asia-Pacific Pimozide Sales Market Share by Application (2020-2025)
Figure 40. Europe Pimozide Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Europe Pimozide Sales Market Share by Country (2020-2031)
Figure 42. Europe Pimozide Revenue Market Share by Country (2020-2031)
Figure 43. Europe Pimozide Sales Market Share by Type (2020-2025)
Figure 44. Europe Pimozide Sales Market Share by Application (2020-2025)
Figure 45. Latin America Pimozide Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Latin America Pimozide Sales Market Share by Country (2020-2031)
Figure 47. Latin America Pimozide Revenue Market Share by Country (2020-2025)
Figure 48. Latin America Pimozide Sales Market Share by Type (2020-2025)
Figure 49. Latin America Pimozide Sales Market Share by Application (2020-2025)
Figure 50. Middle East and Africa Pimozide Revenue Growth Rate 2020-2031 (US$ Million)
Figure 51. Middle East and Africa Pimozide Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Pimozide Revenue Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Pimozide Sales Market Share by Type (2020-2025)
Figure 54. Middle East and Africa Pimozide Sales Market Share by Application (2020-2025)
Figure 55. Pimozide Supply Chain (Upstream and Downstream Market)
Figure 56. Global Production Market Share of Pimozide Raw Materials by Region in 2024
Figure 57. Pimozide Distribution Channels
Figure 58. Global Pimozide Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 59. Global Pimozide Percentage 2020-2031: Online Sales VS Offline Sales
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Pimozide Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Pimozide Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Pimozide Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Pimozide Sales by Region (2020-2025) & (K Units)
Table 5. Global Pimozide Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Pimozide Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Pimozide Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Pimozide Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Pimozide Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Pimozide Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Pimozide Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Pimozide Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Pimozide Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Pimozide Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Pimozide Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Pimozide Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Pimozide Sales Share by Manufacturer (2020-2025)
Table 18. Pimozide Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Pimozide Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Pimozide Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Pimozide Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Pimozide Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Pimozide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pimozide as of 2024)
Table 24. Pimozide Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Pimozide Market
Table 26. Manufacturers Pimozide Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Teva Company Information
Table 29. Teva Description and Business Overview
Table 30. Teva Pimozide Product
Table 31. Teva Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. Teva Sales Proportion of Pimozide by Product in 2024
Table 33. Teva Sales Proportion of Pimozide by Application in 2024
Table 34. Teva Sales Proportion of Pimozide by Geographic Area in 2024
Table 35. Teva Recent Developments
Table 36. Par Pharmaceutical Company Information
Table 37. Par Pharmaceutical Description and Business Overview
Table 38. Par Pharmaceutical Pimozide Product
Table 39. Par Pharmaceutical Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. Par Pharmaceutical Sales Proportion of Pimozide by Product in 2024
Table 41. Par Pharmaceutical Sales Proportion of Pimozide by Application in 2024
Table 42. Par Pharmaceutical Sales Proportion of Pimozide by Geographic Area in 2024
Table 43. Par Pharmaceutical Recent Developments
Table 44. Johnson & Johnson Company Information
Table 45. Johnson & Johnson Description and Business Overview
Table 46. Johnson & Johnson Pimozide Product
Table 47. Johnson & Johnson Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. Johnson & Johnson Sales Proportion of Pimozide by Product in 2024
Table 49. Johnson & Johnson Sales Proportion of Pimozide by Application in 2024
Table 50. Johnson & Johnson Sales Proportion of Pimozide by Geographic Area in 2024
Table 51. Johnson & Johnson Recent Developments
Table 52. Eumedica Company Information
Table 53. Eumedica Description and Business Overview
Table 54. Eumedica Pimozide Product
Table 55. Eumedica Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. Eumedica Sales Proportion of Pimozide by Product in 2024
Table 57. Eumedica Sales Proportion of Pimozide by Application in 2024
Table 58. Eumedica Sales Proportion of Pimozide by Geographic Area in 2024
Table 59. Eumedica Recent Developments
Table 60. Pharmascience Company Information
Table 61. Pharmascience Description and Business Overview
Table 62. Pharmascience Pimozide Product
Table 63. Pharmascience Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Pharmascience Sales Proportion of Pimozide by Product in 2024
Table 65. Pharmascience Sales Proportion of Pimozide by Application in 2024
Table 66. Pharmascience Sales Proportion of Pimozide by Geographic Area in 2024
Table 67. Pharmascience Recent Developments
Table 68. Domina Pharmaceuticals Company Information
Table 69. Domina Pharmaceuticals Description and Business Overview
Table 70. Domina Pharmaceuticals Pimozide Product
Table 71. Domina Pharmaceuticals Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Domina Pharmaceuticals Sales Proportion of Pimozide by Product in 2024
Table 73. Domina Pharmaceuticals Sales Proportion of Pimozide by Application in 2024
Table 74. Domina Pharmaceuticals Sales Proportion of Pimozide by Geographic Area in 2024
Table 75. Domina Pharmaceuticals Recent Developments
Table 76. Aa Pharma Company Information
Table 77. Aa Pharma Description and Business Overview
Table 78. Aa Pharma Pimozide Product
Table 79. Aa Pharma Pimozide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Aa Pharma Sales Proportion of Pimozide by Product in 2024
Table 81. Aa Pharma Sales Proportion of Pimozide by Application in 2024
Table 82. Aa Pharma Sales Proportion of Pimozide by Geographic Area in 2024
Table 83. Aa Pharma Recent Developments
Table 84. North America Pimozide Sales by Country (2020-2025) & (K Units)
Table 85. North America Pimozide Sales by Country (2026-2031) & (K Units)
Table 86. North America Pimozide Revenue by Country (2020-2025) & (US$ Million)
Table 87. North America Pimozide Revenue by Country (2026-2031) & (US$ Million)
Table 88. North America Pimozide Sales by Type (2020-2025) & (K Units)
Table 89. North America Pimozide Sales by Application (2020-2025) & (K Units)
Table 90. Asia-Pacific Pimozide Sales by Region (2020-2025) & (K Units)
Table 91. Asia-Pacific Pimozide Sales by Region (2026-2031) & (K Units)
Table 92. Asia-Pacific Pimozide Revenue by Region (2020-2025) & (US$ Million)
Table 93. Asia-Pacific Pimozide Revenue by Region (2026-2031) & (US$ Million)
Table 94. Asia-Pacific Pimozide Sales by Type (2020-2025) & (K Units)
Table 95. Asia-Pacific Pimozide Sales by Application (2020-2025) & (K Units)
Table 96. Europe Pimozide Sales by Country (2020-2025) & (K Units)
Table 97. Europe Pimozide Sales by Country (2026-2031) & (K Units)
Table 98. Europe Pimozide Revenue by Country (2020-2025) & (US$ Million)
Table 99. Europe Pimozide Revenue by Country (2026-2031) & (US$ Million)
Table 100. Europe Pimozide Sales by Type (2020-2025) & (K Units)
Table 101. Europe Pimozide Sales by Application (2020-2025) & (K Units)
Table 102. Latin America Pimozide Sales by Country (2020-2025) & (K Units)
Table 103. Latin America Pimozide Sales by Country (2026-2031) & (K Units)
Table 104. Latin America Pimozide Revenue by Country (2020-2025) & (US$ Million)
Table 105. Latin America Pimozide Revenue by Country (2026-2031) & (US$ Million)
Table 106. Latin America Pimozide Sales by Type (2020-2025) & (K Units)
Table 107. Latin America Pimozide Sales by Application (2020-2025) & (K Units)
Table 108. Middle East and Africa Pimozide Sales by Country (2020-2025) & (K Units)
Table 109. Middle East and Africa Pimozide Sales by Country (2026-2031) & (K Units)
Table 110. Middle East and Africa Pimozide Revenue by Country (2020-2025) & (US$ Million)
Table 111. Middle East and Africa Pimozide Revenue by Country (2026-2031) & (US$ Million)
Table 112. Middle East and Africa Pimozide Sales by Type (2020-2025) & (K Units)
Table 113. Middle East and Africa Pimozide Sales by Application (2020-2025) & (K Units)
Table 114. Pimozide Key Raw Materials, Industry Status and Trend
Table 115. Pimozide Key Raw Materials and Upstream Suppliers
Table 116. Pimozide Clients Status and Trend
Table 117. Pimozide Typical Clients
Table 118. Pimozide Distributors
Table 119. Pimozide Market Trends
Table 120. Pimozide Market Drivers
Table 121. Pimozide Market Challenges
Table 122. Pimozide Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Pimozide Product Picture
Figure 2. Global Pimozide Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Pimozide Sales Market Share by Type in 2024 & 2031
Figure 4. 1Mg Product Picture
Figure 5. 2Mg Product Picture
Figure 6. 4Mg Product Picture
Figure 7. Global Pimozide Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Pimozide Sales Market Share by Application in 2024 & 2031
Figure 9. Hospitals
Figure 10. Drugstores
Figure 11. Others
Figure 12. Pimozide Report Years Considered
Figure 13. Global Pimozide Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Pimozide Market Size 2020-2031 (US$ Million)
Figure 15. Global Pimozide Sales 2020-2031 (K Units)
Figure 16. Global Pimozide Sales Market Share Forecast by Region (2020-2031)
Figure 17. Global Pimozide Revenue Market Share by Region (2020-2031)
Figure 18. Global Pimozide Sales Market Share Forecast by Type (2020-2031)
Figure 19. Global Pimozide Revenue Market Share Forecast by Type (2020-2031)
Figure 20. Pimozide Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 21. Global Pimozide Sales Market Share Forecast by Application (2020-2031)
Figure 22. Global Pimozide Revenue Market Share Forecast by Application (2020-2031)
Figure 23. Pimozide Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 24. 1Mg of Pimozide Revenue Market Share by Application, 2024 VS 2031
Figure 25. 2Mg of Pimozide Revenue Market Share by Application, 2024 VS 2031
Figure 26. 4Mg of Pimozide Revenue Market Share by Application, 2024 VS 2031
Figure 27. Global Pimozide Sales Share by Manufacturer in 2024
Figure 28. Pimozide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 29. 1Mg Market Sales Proportion by Manufacturer in 2024
Figure 30. 2Mg Market Sales Proportion by Manufacturer in 2024
Figure 31. 4Mg Market Sales Proportion by Manufacturer in 2024
Figure 32. North America Pimozide Revenue 2020-2031 (US$ Million)
Figure 33. North America Pimozide Sales Market Share by Type (2020-2025)
Figure 34. North America Pimozide Sales Market Share by Application (2020-2025)
Figure 35. Asia-Pacific Pimozide Revenue 2020-2031 (US$ Million)
Figure 36. Asia-Pacific Pimozide Sales Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Pimozide Revenue Market Share by Region (2020-2031)
Figure 38. Asia-Pacific Pimozide Sales Market Share by Type (2020-2025)
Figure 39. Asia-Pacific Pimozide Sales Market Share by Application (2020-2025)
Figure 40. Europe Pimozide Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Europe Pimozide Sales Market Share by Country (2020-2031)
Figure 42. Europe Pimozide Revenue Market Share by Country (2020-2031)
Figure 43. Europe Pimozide Sales Market Share by Type (2020-2025)
Figure 44. Europe Pimozide Sales Market Share by Application (2020-2025)
Figure 45. Latin America Pimozide Revenue Growth Rate 2020-2031 (US$ Million)
Figure 46. Latin America Pimozide Sales Market Share by Country (2020-2031)
Figure 47. Latin America Pimozide Revenue Market Share by Country (2020-2025)
Figure 48. Latin America Pimozide Sales Market Share by Type (2020-2025)
Figure 49. Latin America Pimozide Sales Market Share by Application (2020-2025)
Figure 50. Middle East and Africa Pimozide Revenue Growth Rate 2020-2031 (US$ Million)
Figure 51. Middle East and Africa Pimozide Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Pimozide Revenue Market Share by Country (2020-2031)
Figure 53. Middle East and Africa Pimozide Sales Market Share by Type (2020-2025)
Figure 54. Middle East and Africa Pimozide Sales Market Share by Application (2020-2025)
Figure 55. Pimozide Supply Chain (Upstream and Downstream Market)
Figure 56. Global Production Market Share of Pimozide Raw Materials by Region in 2024
Figure 57. Pimozide Distribution Channels
Figure 58. Global Pimozide Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 59. Global Pimozide Percentage 2020-2031: Online Sales VS Offline Sales
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Medical Waste Fluid Solidifier Market Research Report 2025
Jun 12, 25
Global Metalized Bubble Material Market Research Report 2025
Jun 12, 25
Global 70% Isopropyl Rubbing Alcohol Market Research Report 2025
Jun 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232